BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36839967)

  • 1. Effect of Copolymer Properties on the Phase Behavior of Ibuprofen-PLA/PLGA Mixtures.
    Iemtsev A; Klajmon M; Hassouna F; Fulem M
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug-Polymer Compatibility Screening?
    Pavliš J; Mathers A; Fulem M; Klajmon M
    Mol Pharm; 2023 Aug; 20(8):3960-3974. PubMed ID: 37386723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards rational design of API-poly(D, L-lactide-co-glycolide) based micro- and nanoparticles: The role of API-polymer compatibility prediction.
    Iemtsev A; Zumaya ALV; Dinh M; Hassouna F; Fulem M
    Int J Pharm; 2024 Jan; 650():123724. PubMed ID: 38123107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical stability of hydroxypropyl methylcellulose-based amorphous solid dispersions: Experimental and computational study.
    Iemtsev A; Hassouna F; Mathers A; Klajmon M; Dendisová M; Malinová L; Školáková T; Fulem M
    Int J Pharm; 2020 Nov; 589():119845. PubMed ID: 32931845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moisture-induced phase separation and recrystallization in amorphous solid dispersions.
    Luebbert C; Sadowski G
    Int J Pharm; 2017 Oct; 532(1):635-646. PubMed ID: 28867448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The step-wise dissolution method: An efficient DSC-based protocol for verification of predicted API-polymer compatibility.
    Mathers A; Pechar M; Hassouna F; Fulem M
    Int J Pharm; 2023 Dec; 648():123604. PubMed ID: 37981251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
    Mol Pharm; 2017 Jan; 14(1):157-171. PubMed ID: 28043133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Study of DSC-Based Protocols for API-Polymer Solubility Determination.
    Mathers A; Hassouna F; Klajmon M; Fulem M
    Mol Pharm; 2021 Apr; 18(4):1742-1757. PubMed ID: 33656884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amorphous-Amorphous Phase Separation in API/Polymer Formulations.
    Luebbert C; Huxoll F; Sadowski G
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28212300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical stability of API/polymer-blend amorphous solid dispersions.
    Lehmkemper K; Kyeremateng SO; Bartels M; Degenhardt M; Sadowski G
    Eur J Pharm Biopharm; 2018 Mar; 124():147-157. PubMed ID: 29269154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
    Luebbert C; Wessner M; Sadowski G
    Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic Modeling of the Amorphous Solid Dispersion-Water Interfacial Layer and Its Impact on the Release Mechanism.
    Dohrn S; Kyeremateng SO; Bochmann E; Sobich E; Wahl A; Liepold B; Sadowski G; Degenhardt M
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase behavior of pharmaceutically relevant polymer/solvent mixtures.
    Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Int J Pharm; 2020 Mar; 577():119065. PubMed ID: 31988034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
    Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamic phase behavior of API/polymer solid dispersions.
    Prudic A; Ji Y; Sadowski G
    Mol Pharm; 2014 Jul; 11(7):2294-304. PubMed ID: 24870944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of copolymer composition on the phase behavior of solid dispersions.
    Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
    Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-Liquid Equilibrium in Co-Amorphous Systems: Experiment and Prediction.
    Zemánková A; Hassouna F; Klajmon M; Fulem M
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
    Mol Pharm; 2017 Dec; 14(12):4374-4386. PubMed ID: 29050468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.